Funding
← Back to your selection

Premji Invest

Activity from announced rounds

Activity in this selectionOct 15, 2026 · Biotech · Jul 18, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$386M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Lead
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant